Shareholders and financial analysts should address inquiries concerning Novo Nordisk and its business operations to the Investor Relations Officers.
The first day after the end of each quarter until the day of the release of the quarterly report are quiet periods with no broad business discussions with investors and financial analysts.
It is Novo Nordisk’s objective to have a stable, long-term focused, diversified base of institutional investors that share the company’s vision and strategy. Accordingly, the purpose of Investor Relations is to:
Authorised spokespersons to communicate with the investment community (including analysts, stockbrokers, individual and institutional shareholders but excluding the media and rating agencies) are, unless otherwise agreed, Executive Management and Investor Relations. Investor Relations is to be present at all interactions between company representatives and capital markets participants.
Investor Relations maintains an ongoing relationship with investors and financial analysts. The primary channels for this comprise road shows, broker conferences, Capital Market Days and thematic presentations and conference calls.
Analyst meetings and conference calls arranged by Novo Nordisk to discuss quarterly and annual financial performance, material business events and thematic presentations will be simultaneously broadcasted over the internet or via telephone conference call. Advance notice of the meeting, and the simultaneous broadcast, will be made in a company announcement or other method of communication.
Earnings company announcements will be released to newswires and posted on Novo Nordisk’s corporate website at or prior to the commencement of the meeting or call.
When asked to review analyst draft reports and financial models, Investor Relations should limit review and comment to the following: